Načítá se...
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
BACKGROUND: Erythropoiesis-stimulating agents are used to treat anemia in patients with cancer. However, their safety and effectiveness is controversial. We did a systematic review of the clinical efficacy and harms of these agents in adults with anemia related to cancer or chemotherapy. METHODS: We...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Canadian Medical Association
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2683210/ https://ncbi.nlm.nih.gov/pubmed/19407261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.090470 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|